Skip to main content
. 2018 Aug 3;9(60):31637–31649. doi: 10.18632/oncotarget.25827

Table 2. FGFR1/FOXM1/MELK/GLI2/ZEB1/TWIST1 set is a strong prognostic factor independently of clinical and biological parameters.

HR p-value 95% Cl
Risk Score High vs Low 2.82 6.9e-05 [1.69–4.68]
Karno ≥ 70 0.82 0.521 [0.44–1.51]
Tumor resection vs others 1.70 0.070 [0.96–3.04]
Age ≥ 60 1.12 0.657 [0.68–1.84]
Mesenchymal vs Classical 1.17 0.617 [0.63–2.18]
Neural vs Classical 0.79 0.499 [0.40–1.56]
Proneural vs Classical 1.02 0.952 [0.47–2.24]
Non G-CIMP vs G-CIMP 2.23 0.129 [0.79–6.28]
MGMT methylated vs non methylated 0.54 0.011 [0.33–0.87]